Press Releases

LEXINGTON, Ky., Jan. 20, 2020 /PRNewswire/ -- New Vista today announced the retirement of Paul R. Beatrice as Chief Executive Officer at the end of 2020.  Linda Watt, New Vista Board of Directors Chair observed that, "During Paul's tenure as CEO, New Vista has met the challenges of an ever-cha

NEW YORK, Jan. 20, 2020 /PRNewswire/ -- bodySCULPT® the premier plastic surgery practice based in New York City, NY, announces two breakthrough non-invasive solutions from InMode - EVOKE, a complete facial remodeling device; and EVOLVE, the ultimate in thermal body & skin contouring treatments. bodySCULPT® is one of the first

BOSTON, Jan. 20,  2020 /PRNewswire/ -- XRHealth, formerly known as VRHealth, the leader in extended reality and therapeutic applications, today announced that they partnered with the VA St.

SUZHOU, China, Jan. 20, 2020 /PRNewswire/ -- TenNor Therapeutics, a clinical-stage, global biopharmaceutical company has received FDA Orphan Drug Designation for TNP-2092 to treat prosthetic joint infections. Medical devices such as prosthetic joints, central venous catheters and artificial heart valves are being used more frequently and biofilm infections associa

VANCOUVER, Jan. 20, 2020 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a clinical stage biopharmaceutical company developing therapeutics targeting diseases with high unmet medical needs, today revealed the rare cannabinoid  cannabinol ("CBN") as the active pharmaceutical ingredient ("API") in its two product cand

Crescita to Distribute NCTF® and ART FILLER® Injectables in Canada LAVAL, QC, Jan. 20, 2020  /PRNewswire/ - Crescita Therapeutics Inc. (TSX: CTX) and (OTC US: CRRTF) ("Crescita" or the "Company"), a commercial dermatology com

WESTON, Fla., Jan. 20, 2020 /PRNewswire/ -- ZyVersa Therapeutics, Inc., (ZyVersa) a clinical stage specialty biopharmaceutical company developing first-in-class drugs for treatment of inflammatory and renal diseases, is pleased to announce release of a new video demonstrating how inflammasomes stimulate and perpetuate inflammation, and how a novel inflammasome inhibitor

REDWOOD CITY, Calif., Jan. 20, 2020 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that Donald A. Middlebrook has been named Vice President, Clinical, Regulatory and Quality, reporting directly to Ch

ORLANDO, Fla., Jan. 20, 2020 /PRNewswire/ -- NAVC Veterinary Meeting and Expo (VMX) booth #1941 -- Today, Antech Diagnostics, part of Mars Petcare, announced a milestone in providing the veterinary community with accurate predictions about whether or not a cat will develop chronic kidney disease (CKD) within two years. Now more than 100,000 times,

VAUGHN, Ontario, Jan. 20, 2020 /PRNewswire/ -- Ignite International Brands, Ltd. (CSE:BILZ, OTCQX: BILZF) ("IGNITE" or the "Company") today announced the expansion of its product offerings with the formation of a new division - IGNITE Beverages. IGNITE Beverages is expected to focus on the development and distribution of innovative premium beverages ac